Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
224.90
+0.50 (0.22%)
At close: Nov 14, 2024
7.15%
Market Cap 199.36B
Revenue (ttm) 68.81B
Net Income (ttm) 20.24B
Shares Out 886.45M
EPS (ttm) 22.83
PE Ratio 9.85
Forward PE 9.49
Dividend 11.00 (4.89%)
Ex-Dividend Date Nov 24, 2024
Volume 214,302
Open 225.90
Previous Close 224.40
Day's Range 224.50 - 225.90
52-Week Range 197.20 - 249.80
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 23, 2024

About SQURPHARMA

Square Pharmaceuticals PLC. and its subsidiaries develop, manufacture, and market drugs for health care for various live species in Bangladesh. The company offers generic pharmaceuticals, basic chemicals, and animal health products. It also markets crop care products. Square Pharmaceuticals PLC. also exports its products to approximately 42 countries. The company was founded in 1958 and is based in Dhaka, Bangladesh. Square Pharmaceuticals PLC. operates as a subsidiary of Square Group. [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 12,503
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In 2023, SQURPHARMA's revenue was 62.75 billion, an increase of 8.94% compared to the previous year's 57.60 billion. Earnings were 18.98 billion, an increase of 4.53%.

Financial Statements

News

There is no news available yet.